Assured Guaranty is a Bermuda-based holding company that provides, through its operating subsidiaries, credit protection products to the U.S. and international public finance including infrastructure and structured finance markets. The company markets its financial guaranty insurance directly to issuers and underwriters of public finance and structured finance securities as well as to investors in such obligations. The company guarantees obligations issued in the U.S. and the U.K, and also guarantees obligations issued in other countries and regions. The company's financial guaranty direct and assumed businesses provide credit protection on public finance, infrastructure and structured finance obligations.

Calithera Biosciences is a clinical-stage bio-pharmaceutical company focused on fighting cancer and other life threatening diseases by discovering and developing small molecule drugs that targets cellular metabolism. The company's main product candidate, telaglenastat (CB-839), is a selective glutaminase inhibitor that blocks glutamine consumption in tumor cells and demonstrates synergistic antitumor effects with multiple anticancer therapies.Co.'s other product candidate, INCB001158, is an oral inhibitor of arginase, an enzyme that depletes the amino acid arginine, a key metabolic nutrient for T-cells and it is being co-developed with Incyte Corporation, for oncology and hematology indications.

Diebold Nixdorf is engaged in enabling Connected Commerce?. The company automates, digitizes and transforms the way people bank and shop. The company's integrated solutions connect digital and physical channels for consumers. The company's operating structure is focused on its two customer segments consisting of Banking and Retail. The products for banking customers consist of cash recyclers and dispensers, deposit terminals, teller automation and kiosk technologies, as well as physical security solutions. The retail product portfolio includes modular, integrated and mobile point of sale and self-checkout terminals that meet automation and omnichannel requirements of consumers.

Dime Community Bancshares is a savings and loan holding company. Through its subsidiary, Dime Community Bank (the Bank), the company is engaged in commercial banking and financial services. The Bank's primary business is gathering deposits from customers within its market area and via the internet, and investing them primarily in multifamily residential, commercial real estate, and, to an extent, commercial and industrial loans and one-to-four family residential real estate loans, as well as mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises, and corporate debt and equity securities.

Five Prime Therapeutics is a clinical-stage biotechnology company focused on discovering and developing protein therapeutics. The company's key product candidates are: FPA150, which is a CD8 T cell checkpoint inhibitor antibody that targets B7-H4 that it is studying in a clinical trial in multiple cancers; FPT155, which is a soluble CD80 fusion protein that enhances co-stimulation of T cells through CD28 that the company is studying in a clinical trial in multiple cancers; and Cabiralizumab (FPA008) is an antibody that the company and its partner Bristol-Myers Squibb Company, or BMS, are studying in clinical trials in multiple cancers in combination with BMS's PD-1 immune checkpoint inhibitor, Opdivo? (nivolumab).

Opko Health is a healthcare company. The company manages two segments: Diagnostics, which provides laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare; and Pharmaceutical, which includes Rayaldee for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease (CKD) and vitamin D insufficiency, and Alpharen (Fermagate Tablets) for the treatment of hyperphosphatemia in CKD patients requiring regular hemodialysis.

Southern National Bancorp of Virginia is a bank holding company. Through its subsidiary, Sonabank, the company provides financial services to individuals and small and medium sized businesses. The company focuses on making loans secured primarily by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses, as well as loans to individuals. The company is a Small Business Administration lender. The company also invests in real estate-related securities, including collateralized mortgage obligations and agency mortgage backed securities. In addition, the company provides deposit products, including checking (NOW), savings, money market accounts and certificates of deposit.